19
Participants
Start Date
April 30, 2006
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
L-N^G monomethyl arginine (L-NMMA)
L-NMMA was infused at a dose of 1 mg/kg over 10 minutes to competitively inhibit the production of nitric oxide. Ultrasound imaging of the saphenous vein \[arterial\] bypass at baseline, and following an ischemic stimulus, administration of sublingual nitroglycerin, and intravenous administration of L-NMMA.
Brigham and Women's Hospital, Boston
Brigham and Women's Hospital
OTHER